BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21446135)

  • 1. [Clinical and prognostic significance of CD34 expression in bone marrow biopsies in myelodysplastic syndrome].
    Savić A; Rajić N; Vlaisavljević N; Cemerikić-Martinović V; Popović S
    Med Pregl; 2010; 63(7-8):487-91. PubMed ID: 21446135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes.
    Min YH; Lee ST; Min DW; Kim TS; Lee CH; Lee BK; Hahn JS; Ko YW
    Yonsei Med J; 1995 Mar; 36(1):1-8. PubMed ID: 7537931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD34 immunohistochemistry of bone marrow biopsies: prognostic significance in primary myelodysplastic syndromes.
    Soligo DA; Oriani A; Annaloro C; Cortelezzi A; Calori R; Pozzoli E; Nosella D; Orazi A; Deliliers GL
    Am J Hematol; 1994 May; 46(1):9-17. PubMed ID: 7514357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry.
    Kanter-Lewensohn L; Hellström-Lindberg E; Kock Y; Elmhorn-Rosenborg A; Ost A
    Eur J Haematol; 1996 Mar; 56(3):124-9. PubMed ID: 8598230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromes.
    Oriani A; Annaloro C; Soligo D; Pozzoli E; Cortelezzi A; Lambertenghi Deliliers G
    Br J Haematol; 1996 Feb; 92(2):360-4. PubMed ID: 8603000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):234-8. PubMed ID: 21418866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
    Xie W; Wang X; Du W; Liu W; Qin X; Huang S
    Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotyping in myelodysplastic syndromes can add prognostic information to well-established and new clinical scores.
    Reis-Alves SC; Traina F; Harada G; Campos PM; Saad ST; Metze K; Lorand-Metze I
    PLoS One; 2013; 8(12):e81048. PubMed ID: 24324660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
    Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M
    Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.
    Baur AS; Meugé-Moraw C; Schmidt PM; Parlier V; Jotterand M; Delacrétaz F
    Eur J Haematol; 2000 Feb; 64(2):71-9. PubMed ID: 10997326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes.
    Lepelley P; Soenen V; Preudhomme C; Lai JL; Cosson A; Fenaux P
    Leukemia; 1994 Jun; 8(6):998-1004. PubMed ID: 7516032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of CD34(-) and CD34(+) cell apoptosis and proliferation in bone marrow of patients with MDS and their impact on survival.
    Xia B; Guo Q; Zhao DD; Zhao HF; Han XP; Wang H; Wu XX; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1392-7. PubMed ID: 23257440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased CD133 expression in bone marrow of myelodysplastic syndromes.
    Auberger J; Dlaska M; Auberger T; Gunsilius E; Wöll E; Hilbe W
    Leuk Res; 2005 Sep; 29(9):995-1001. PubMed ID: 16038725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abnormalities of CD34+ cells differentiation and bone marrow cell cycle in myelodysplastic syndrome].
    Li LJ; Fu R; Shao ZH; Wang HQ; Yue LZ; Ruan EB; Liu H; Wang J; Wang HL
    Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):963-6. PubMed ID: 21211213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
    Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
    Della Porta MG; Malcovati L; Boveri E; Travaglino E; Pietra D; Pascutto C; Passamonti F; Invernizzi R; Castello A; Magrini U; Lazzarino M; Cazzola M
    J Clin Oncol; 2009 Feb; 27(5):754-62. PubMed ID: 19103730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
    Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
    Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
    Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes.
    Tang G; Wang SA; Menon M; Dresser K; Woda BA; Hao S
    Leuk Res; 2011 Jun; 35(6):766-70. PubMed ID: 21367453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of G-CSF and GM-CSF receptors on CD34 positive cells in aplastic anemia and myelodysplastic syndrome patients and its significance].
    Xu HZ; Li A; Yu Y; Li JF; Liu X; Wang XH; Wang X; Xu GL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1308-11. PubMed ID: 19099633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.